Literature DB >> 30076629

LGI1 and CASPR2 neurological autoimmunity in children.

A Sebastian López-Chiriboga1, Christopher Klein1,2, Anastasia Zekeridou1, Andrew McKeon1,2, Divyanshu Dubey2, Eoin P Flanagan1, Vanda A Lennon1,2,3, Jan-Mendelt Tillema1, Elaine C Wirrell1, Marc C Patterson1, Avi Gadoth2, J Gregory Aaen4, J Nicholas Brenton5, Jonathan D Bui6, Amanda Moen7, Catherine Otten8, Amanda Piquet9, Sean J Pittock1,2.   

Abstract

The clinical phenotype of leucine-rich glioma-inactivated protein 1 (LGI1) and contactin-associated proteinlike 2 (CASPR2) autoimmunity is well defined in adults. Data for children are limited (<10 cases). Among 13,319 pediatric patients serologically tested for autoimmune neurological disorders (2010-2017), 264 were seropositive for voltage-gated potassium channel-complex-IgG (radioimmunoprecipitation). Only 13 (4.9%) were positive by transfected cell-binding assay for LGI1-IgG (n = 7), CASPR2-IgG (n = 3), or both (n = 3). This is significantly less than in adults. Encephalopathy, seizures, and peripheral nerve hyperexcitability were common, as was coexisting autoimmunity. No faciobrachial dystonic seizures or cancers were identified. Functional neurologic disorders were frequently the initial diagnosis, and immunotherapy appeared beneficial. Ann Neurol 2018;84:473-480.
© 2018 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30076629     DOI: 10.1002/ana.25310

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  12 in total

Review 1.  Autoimmune seizures and epilepsy.

Authors:  Christian Geis; Jesus Planagumà; Mar Carreño; Francesc Graus; Josep Dalmau
Journal:  J Clin Invest       Date:  2019-02-04       Impact factor: 14.808

Review 2.  Autoimmune Epilepsy.

Authors:  Khalil S Husari; Divyanshu Dubey
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

3.  Contactin-Associated Protein-Like 2 (CASPR2)-Associated Movement Disorder in a Child.

Authors:  Ram Bhupal Reddy Nagireddy; Anand Kumar; Deepika Joshi
Journal:  Mov Disord Clin Pract       Date:  2021-08-20

Review 4.  Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management.

Authors:  Elia Sechi; Eoin P Flanagan
Journal:  Front Neurol       Date:  2021-07-07       Impact factor: 4.003

Review 5.  Single-cell approaches to investigate B cells and antibodies in autoimmune neurological disorders.

Authors:  Alicia Zou; Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Cell Mol Immunol       Date:  2020-07-29       Impact factor: 22.096

Review 6.  Understanding Childhood Neuroimmune Diseases of the Central Nervous System.

Authors:  Sara Matricardi; Giovanni Farello; Salvatore Savasta; Alberto Verrotti
Journal:  Front Pediatr       Date:  2019-12-19       Impact factor: 3.418

7.  Developing Consensus in the Assessment and Treatment Pathways for Autoimmune Encephalitis in Child and Adolescent Psychiatry.

Authors:  GenaLynne C Mooneyham; Vladimir Ferrafiat; Erin Stolte; D Catherine Fuchs; David Cohen
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

8.  Pediatric autoimmune encephalitis: Recognition and diagnosis.

Authors:  Marienke A A M de Bruijn; Arlette L Bruijstens; Anna E M Bastiaansen; Agnes van Sonderen; Marco W J Schreurs; Peter A E Sillevis Smitt; Rogier Q Hintzen; Rinze F Neuteboom; Maarten J Titulaer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-02-11

9.  Clinical approach to the diagnosis of autoimmune encephalitis in the pediatric patient.

Authors:  Tania Cellucci; Heather Van Mater; Francesc Graus; Eyal Muscal; William Gallentine; Marisa S Klein-Gitelman; Susanne M Benseler; Jennifer Frankovich; Mark P Gorman; Keith Van Haren; Josep Dalmau; Russell C Dale
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-01-17

Review 10.  The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis.

Authors:  Sudarshini Ramanathan; Adam Al-Diwani; Patrick Waters; Sarosh R Irani
Journal:  J Neurol       Date:  2019-10-26       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.